Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocort versus Depo-Medrol for active rheumatoid arthritis flare
NL-OMON45232Phase 3Active, not recruiting
- Sponsor
- Sun Pharma
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in rheumatoid arthritis (RA), sponsored by Sun Pharma. Started Mar 2016; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON45232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45232.